Approval · Notice of Compliance 20389 · 2018
CORIFACT 1250: Notice of Compliance 20389
Issued January 19, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20389
- Date
- January 19, 2018
- Company
- Csl Behring Canada IncOttawa, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling udpates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CORIFACT 1250 | Not yet assigned | — |
| CORIFACT 250 | Not yet assigned | — |
Medicinal ingredients
- FACTOR XIII (HUMAN) 1,250 UNIT per VIAL
- FACTOR XIII (HUMAN) 250 UNIT per VIAL